Eyelten Therapeutics Overview
- Year Founded
-
2009
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Eyelten Therapeutics General Information
Description
Provider of pharmaceutical therapies for the treatment macular degeneration. The company offers medical preparations and treatment options for macular degeneration and other age related problems.
Contact Information
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
- 4041 Forest Park Avenue
- Saint Louis, MO 63108
- United States
+1 (314)
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
- 4041 Forest Park Avenue
- Saint Louis, MO 63108
- United States
+1 (314)
Eyelten Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Jan-2016 | Completed | Out of Business | |||
| 1. Early Stage VC | Completed | Startup |
Eyelten Therapeutics FAQs
-
When was Eyelten Therapeutics founded?
Eyelten Therapeutics was founded in 2009.
-
Where is Eyelten Therapeutics headquartered?
Eyelten Therapeutics is headquartered in Saint Louis, MO.
-
What industry is Eyelten Therapeutics in?
Eyelten Therapeutics’s primary industry is Biotechnology.
-
Is Eyelten Therapeutics a private or public company?
Eyelten Therapeutics is a Private company.
-
What is Eyelten Therapeutics’s current revenue?
The current revenue for Eyelten Therapeutics is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
